Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR-3167 vs Insulin Degludec in Type 2 Diabetes
NCT07913061Phase 3Not yet recruiting
- Sponsor
- Hengrui
- Start
- Nov 2026
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
A Phase 3 trial of SHR-3167 in type 2 diabetes mellitus (T2DM), sponsored by Hengrui. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
SHR-3167
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07913061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07913061.